Pharma News, 2020

The World Health Organization warned Thursday that Covid-19 restrictions had crippled measles vaccination efforts amid fears for the impact on cases and deaths following a spike last year.

Months after drugmakers launched an unprecedented COVID-19 research effort, some existing medicines have turned in promising results—but more of them have failed against the virus.

The UK’s National Institute for Health and Care Excellence (NICE) has given a green light to Sanofi’s Cablivi for acquired thrombotic thrombocytopenic purpura (aTTP) – a rare and...

Pfizer’s investigational oral Janus kinase 1 (JAK1) inhibitor abrocitinib has scored positive top-line results in a phase III atopic dermatitis trial.

LONDON (Reuters) - High levels of so-called “T cells” that respond to the coronavirus could be sufficient to offer protection against infection, an English study said on Tuesday, adding to...

Every day, ten Americans die from asthma.

TOKYO & AUSTIN, Texas--(BUSINESS WIRE)-- Taiho Pharmaceutical Co.

A new UC Riverside study shows flame retardants found in nearly every American home cause mice to give birth to offspring that become diabetic.

While the novel coronavirus continues to disrupt the lives of people, new researches are being done everyday to contain the deadly virus.

SHANGHAI — As China begins rolling out its COVID-19 vaccines, the country is trialling an unconventional approach to speed up the program.

(Reuters) - Moderna Inc said on Wednesday it was on track to report early data from a late-stage trial of its experimental coronavirus vaccine later this month, and could file for U.

ZURICH (Reuters) - Novartis's NOVN.